Literature DB >> 20036015

Oxidative stress in Egyptian children with autism: relation to autoimmunity.

Gehan A Mostafa1, Eman S El-Hadidi, Doaa H Hewedi, Mohammed M Abdou.   

Abstract

UNLABELLED: We are the first to study the relationship between oxidative stress (by measuring plasma F2-isoprostane, as a marker of lipid peroxidation, and glutathione peroxidase, as an antioxidant enzyme) and autoimmunity (as indicated by serum antineuronal antibodies) in a group of 44 Egyptian autistic children and 44 healthy matched-children. Our results showed that oxidative stress was found in 88.64% of autistic children. Oxidative stress, resulting from elevated plasma F2-isoprostane and/or reduced glutathione peroxidase, had significant risk for antineuronal positivity, which was found in 54.5% of autistic children, (odds ratio: 12.38 and 6.43, respectively, confidence interval: 1.37-112.10 and 1.21-34.19, respectively).
CONCLUSIONS: the strong association between oxidative stress and autoimmunity in autistic children may indicate the possible role of oxidative stress, through induction of autoimmunity, in some autistic patients. Therefore, studies considering the role of antioxidants and immunotherapy in amelioration of autistic manifestations are recommended. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036015     DOI: 10.1016/j.jneuroim.2009.12.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  32 in total

1.  Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-04-25       Impact factor: 8.322

Review 2.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Autism spectrum disorders (ASD) in Africa: a perspective.

Authors:  M O Bakare; K M Munir
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2011-07

Review 4.  Impaired Redox Control in Autism Spectrum Disorders: Could It Be the X in GxE?

Authors:  Vanja Mandic-Maravic; Marija Pljesa-Ercegovac; Marija Mitkovic-Voncina; Ana Savic-Radojevic; Dusica Lecic-Tosevski; Tatjana Simic; Milica Pejovic-Milovancevic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

5.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  Penelope Ae Main; Manya T Angley; Catherine E O'Doherty; Philip Thomas; Michael Fenech
Journal:  Nutr Metab (Lond)       Date:  2012-04-24       Impact factor: 4.169

6.  Necrosis is increased in lymphoblastoid cell lines from children with autism compared with their non-autistic siblings under conditions of oxidative and nitrosative stress.

Authors:  Penelope A E Main; Philip Thomas; Adrian Esterman; Michael F Fenech
Journal:  Mutagenesis       Date:  2013-07       Impact factor: 3.000

7.  The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas.

Authors:  Gehan Ahmed Mostafa; Geir Bjørklund; Mauricio A Urbina; Laila Yousef Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2016-06-01       Impact factor: 3.584

8.  Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis.

Authors:  A Ghanizadeh
Journal:  Mol Syndromol       Date:  2011-10-12

9.  Elevated serum levels of interleukin-17A in children with autism.

Authors:  Laila Yousef Al-Ayadhi; Gehan Ahmed Mostafa
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

10.  Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism.

Authors:  Mostafa I Waly; Mady Hornig; Malav Trivedi; Nathaniel Hodgson; Radhika Kini; Akio Ohta; Richard Deth
Journal:  Autism Res Treat       Date:  2012-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.